RxDoctor Payments Data

Matthew Gall

Medical Oncology · Burnsville, MNNPI 1457320509

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $22,680 of the $35,790 with a category attached, or 63.4%. Merck accounts for 81.8% of it on its own, with 17 other manufacturers making up the rest.

$35,790in general payments, 2019–2025

Across 75 payments — averaging $477.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$29K
  • Bayer$6K
  • Incyte Corporation$109
  • Astellas Pharma US Inc$106
  • E.r. Squibb & Sons, L.L.C.$82
  • Johnson & Johnson$34
  • plus $258 from 12 others

What the payments were for

  • Consulting fees$5,00014%
  • Speaking & faculty fees$22,68063%
  • Travel & lodging$6,92819%
  • Food & beverage$1,1063%
  • Education$760%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,790 in reported general payments places this provider in the 80th percentile of 133 medical oncology providers in Minnesota.

See all medical oncology providers in Minnesota →

Other medical oncology in Burnsville

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →